Dexcom, Inc.

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instance_of gptkb:Company
gptkbp:acquisition gptkb:Type_Zero_Technologies
Glytec
gptkbp:awards Best Places to Work
gptkbp:ceo gptkb:Kevin_Sayer
gptkbp:clinical_trial ongoing
gptkbp:community_involvement diabetes awareness programs
gptkbp:customer_base millions of users worldwide
gptkbp:employees over 2,000
gptkbp:founded gptkb:1999
gptkbp:founder gptkb:Kevin_Sayer
gptkbp:global_presence operates in over 30 countries
gptkbp:headquarters gptkb:San_Diego,_California
gptkb:United_States
https://www.w3.org/2000/01/rdf-schema#label Dexcom, Inc.
gptkbp:industry gptkb:medical_devices
gptkbp:invention over 200 patents
gptkbp:investment $1 billion (2021)
gptkbp:market_cap $40 billion (2021)
gptkbp:market_launch Dexcom G4 (2012)
Dexcom G4 PLATINUM (2014)
Dexcom G5 (2015)
Dexcom G6 (2018)
Dexcom G6 PRO (2019)
Dexcom G7 (2022)
Dexcom G7 PRO (2023)
Dexcom SEVEN (2009)
Dexcom STS (2006)
gptkbp:mission empower people with diabetes
gptkbp:partnership gptkb:diabetes
gptkb:Abbott_Laboratories
gptkb:Google_Cloud
gptkb:Verily_Life_Sciences
gptkb:JDRF
gptkbp:product gptkb:Dexcom_G7
gptkb:Dexcom_Share
gptkb:Dexcom_G6
Dexcom Clarity
gptkbp:products continuous glucose monitoring systems
gptkbp:regulatory_compliance FDA approved
gptkbp:research_and_development significant investment
gptkbp:revenue $1.93 billion (2020)
gptkbp:stock_symbol gptkb:DXCM
gptkbp:subsidiary Dexcom Canada, Inc.
Dexcom International, Inc.
gptkbp:sustainability_initiatives environmental responsibility programs
gptkbp:target_market diabetes patients
gptkbp:technology gptkb:sensors
gptkbp:vision transform diabetes management
gptkbp:website www.dexcom.com
gptkbp:bfsParent gptkb:Tandem_Diabetes_Care,_Inc.
gptkbp:bfsLayer 7